Cavitary tuberculosis: the gateway of disease transmission.
Urbanowski ME, Ordonez AA, Ruiz-Bedoya CA, Jain SK, Bishai WR.
Lancet Infect Dis. 2020 Jun;20(6):e117-e128. doi: 10.1016/S1473-3099(20)30148-1. Epub 2020 May 5.
Cavitary pulmonary tuberculosis during treatment with guselkumab.
Cerejeira A, Canelas G, Vide J, Duro R, Azevedo F, Magina S.
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e488-e490. doi: 10.1111/jdv.17992. Epub 2022 Feb 17.
Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P.
Int J Tuberc Lung Dis. 2016 Nov;20(11):1522-1528. doi: 10.5588/ijtld.16.0217.
Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis.
Yang Y, Zhang S, Dong Z, Xu Y, Hu X, Jiang G, Fan L, Duan L.
J Cardiothorac Surg. 2021 Mar 17;16(1):22. doi: 10.1186/s13019-021-01401-5.
Cavitary pulmonary tuberculosis HIV-related.
Busi Rizzi E, Schininà V, Palmieri F, Girardi E, Bibbolino C.
Eur J Radiol. 2004 Nov;52(2):170-4. doi: 10.1016/j.ejrad.2004.04.007.
Historical Treatment of Cavitary Tuberculosis.
Ghosh S, Haramati LB.
Mayo Clin Proc. 2022 Sep;97(9):1601. doi: 10.1016/j.mayocp.2022.05.013.
Chronic Cavitary Pulmonary Aspergillosis: Complication of Pulmonary Tuberculosis.
Tiwari B, Adhikari S, Ghimire M, Singh S, Kafle A.
J Nepal Health Res Counc. 2024 Jun 22;22(1):205-208. doi: 10.33314/jnhrc.v22i01.4344.
Bilateral chronic cavitary pulmonary aspergillomas in an adult patient with recurrent tuberculosis: a case report and literature review.
Tadesse TM, Shegene O, Abebe SD, Tadesse EM, Sahiledengle B, Jima MT.
J Med Case Rep. 2024 Oct 11;18(1):491. doi: 10.1186/s13256-024-04801-y.
Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9.
Ordonez AA, Tasneen R, Pokkali S, Xu Z, Converse PJ, Klunk MH, Mollura DJ, Nuermberger EL, Jain SK.
Dis Model Mech. 2016 Jul 1;9(7):779-88. doi: 10.1242/dmm.025643. Epub 2016 May 26.
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy.
Musso M, Di Gennaro F, Gualano G, Mosti S, Cerva C, Fard SN, Libertone R, Di Bari V, Cristofaro M, Tonnarini R, Castilletti C, Goletti D, Palmieri F.
Infection. 2021 Oct;49(5):1061-1064. doi: 10.1007/s15010-021-01576-y. Epub 2021 Jan 17.
